| Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma M Cadamuro, S Brivio, J Mertens, M Vismara, A Moncsek, C Milani, ... Journal of hepatology 70 (4), 700-709, 2019 | 128 | 2019 |
| Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation SD Morton, M Cadamuro, S Brivio, M Vismara, T Stecca, M Massani, ... Oncotarget 6 (28), 26052, 2015 | 66 | 2015 |
| The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells C Reduzzi, M Vismara, L Gerratana, M Silvestri, F De Braud, ... Seminars in Cancer Biology 60, 344-350, 2020 | 40 | 2020 |
| Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy E Ortolan, V Appierto, M Silvestri, R Miceli, S Veneroni, S Folli, G Pruneri, ... ESMO open 6 (2), 100086, 2021 | 36 | 2021 |
| Analysis of single circulating tumor cells in renal cell carcinoma reveals phenotypic heterogeneity and genomic alterations related to progression V Cappelletti, E Verzoni, R Ratta, M Vismara, M Silvestri, R Montone, ... International journal of molecular sciences 21 (4), 1475, 2020 | 33 | 2020 |
| Circulating tumor cell clusters are frequently detected in women with early-stage breast cancer C Reduzzi, S Di Cosimo, L Gerratana, R Motta, A Martinetti, A Vingiani, ... Cancers 13 (10), 2356, 2021 | 32 | 2021 |
| A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer C Reduzzi, M Vismara, M Silvestri, L Celio, M Niger, G Peverelli, ... International journal of cancer 146 (12), 3495-3503, 2020 | 22 | 2020 |
| Single-cell phenotypic and molecular characterization of circulating tumor cells isolated from cryopreserved peripheral blood mononuclear cells of patients with lung cancer and … M Vismara, C Reduzzi, M Silvestri, F Murianni, G Lo Russo, O Fortunato, ... Clinical Chemistry 68 (5), 691-701, 2022 | 16 | 2022 |
| Detection of genomically aberrant cells within circulating tumor microemboli (CTMs) isolated from early-stage breast cancer patients M Silvestri, C Reduzzi, G Feliciello, M Vismara, T Schamberger, C Köstler, ... Cancers 13 (6), 1409, 2021 | 11 | 2021 |
| Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer M Silvestri, M Dugo, M Vismara, L De Cecco, D Lanzoni, A Vingiani, ... Scientific Reports 12 (1), 1470, 2022 | 10 | 2022 |
| Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation. Oncotarget. 2015; 6: 26052–26064 SD Morton, M Cadamuro, S Brivio, M Vismara, T Stecca, M Massani, ... Epub 2015/08/25. doi: 10.18632/oncotarget. 4482. PubMed PMID: 26296968, 0 | 5 | |
| Circulating tumor cells (ctcs) heterogeneity in metastatic breast cancer: different approaches for different needs M Vismara, C Reduzzi, MG Daidone, V Cappelletti Circulating Tumor Cells in Breast Cancer Metastatic Disease, 81-91, 2020 | 4 | 2020 |
| JNK signaling activated by Platelet-Derived Growth Factor D (PDGF-D) stimulates secretion of Vascular Endothelial Growth Factor-C (VEGF-C) by cancer-associated fibroblasts to … M Cadamuro, M Vismara, S Brivio, A Furlanetto, M Strazzabosco, L Fabris Digestive and Liver Disease 47, e22-e23, 2015 | 3 | 2015 |
| A novel subpopulation of circulating tumor cells in patients with cholangiocarcinoma. C Reduzzi, M Vismara, M Silvestri, L Celio, A Raimondi, M Torchio, ... Journal of Clinical Oncology 37 (15_suppl), e15637-e15637, 2019 | 2 | 2019 |
| Secretion of Vascular Endothelial Growth Factor-C by Cancer-Associated Fibroblasts (CAF) Is Stimulated by Platelet-Derived Growth Factor D (PDGF-D) and Promotes … M Cadamuro, M Vismara, S Brivio, A Bovo, M Strazzabosco, L Fabris Gastroenterology 150 (4), 1124-1124, 2016 | 2 | 2016 |
| Acquired Resistance Mechanisms to PD-L1 Blockade in a Patient With Microsatellite Instability-High Extrahepatic Cholangiocarcinoma M Niger, F Nichetti, F Dell'Angelo, V Cappelletti, C Pircher, M Vismara, ... JCO Precision Oncology 6, e2100472, 2022 | 1 | 2022 |
| P0220: JNK signaling activated by platelet-derived growth factor D (PDGF-D) stimulates secretion of vascular endothelial growth factor-C (VEGF-C) by cancer-associated … M Cadamuro, M Vismara, S Brivio, A Furlanetto, M Strazzabosco, L Fabris Journal of Hepatology, S389, 2015 | 1 | 2015 |
| Isolation and Genomic Analysis of Circulating Tumor Cell Clusters in Cancer Patients C Reduzzi, M Vismara, T Schamberger, M Silvestri, R Motta, BM Polzer, ... Single Cell Analysis: Methods and Protocols, 101-117, 2024 | | 2024 |
| 136P Paths of chromosomal instability and copy number alteration in circulating tumor cells of progressing early-stage breast cancer patients M Silvestri, C Reduzzi, M Vismara, M Valenti, S Folli, M Cristofanilli, ... Annals of Oncology 33, S1426, 2022 | | 2022 |
| 59P Primary tumour and circulating tumour cell (CTC) copy number alterations (CNAs) in triple negative breast cancer (TNBC) patients (pts) treated with neoadjuvant chemotherapy … S Di Cosimo, M Silvestri, M Dugo, M Vismara, C Reduzzi, G Pruneri, ... Annals of Oncology 31, S35-S36, 2020 | | 2020 |
